APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atorvastatin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atorvastatin Market Analysis and Forecast 2026-2032

23 December 2025192 pages

Choose your research edition.

Industry ResearchAtorvastatin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Atorvastatin Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Atorvastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atorvastatin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Atorvastatin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Atorvastatin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atorvastatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atorvastatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atorvastatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atorvastatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atorvastatin include Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Pfizer, Morepen, DSM Sinochem Pharmaceuticals, Combi-Blocks, Cadila Pharmaceuticals and Apotex Pharmachem, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atorvastatin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atorvastatin, also provides the sales of main regions and countries. Of the upcoming market potential for Atorvastatin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atorvastatin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atorvastatin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atorvastatin sales, projected growth trends, production technology, application and end-user industry.

Atorvastatin Segment by Company

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Pfizer

Morepen

DSM Sinochem Pharmaceuticals

Combi-Blocks

Cadila Pharmaceuticals

Apotex Pharmachem

Atorvastatin Segment by Type

Chemical Synthesis

Biocatalysis

Atorvastatin Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Atorvastatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atorvastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atorvastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atorvastatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atorvastatin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atorvastatin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atorvastatin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atorvastatin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chemical Synthesis Major Manufacturers Table 3. Biocatalysis Major Manufacturers Table 4. Global Atorvastatin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacy Major Manufacturers Table 6. Online Pharmacy Major Manufacturers Table 7. Retail Pharmacy Major Manufacturers Table 8. Atorvastatin Industry Trends Table 9. Atorvastatin Industry Drivers Table 10. Atorvastatin Industry Opportunities and Challenges Table 11. Atorvastatin Industry Restraints Table 12. Global Atorvastatin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Atorvastatin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Atorvastatin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Atorvastatin Revenue Market Share by Region (2021-2026) Table 16. Global Atorvastatin Revenue Market Share by Region (2027-2032) Table 17. Global Atorvastatin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 18. Global Atorvastatin Sales by Region (2021-2026) & (k tons) Table 19. Global Atorvastatin Sales by Region (2027-2032) & (k tons) Table 20. Global Atorvastatin Sales Market Share by Region (2021-2026) Table 21. Global Atorvastatin Sales Market Share by Region (2027-2032) Table 22. Global Atorvastatin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Atorvastatin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Atorvastatin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Atorvastatin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Atorvastatin Sales Price (US$/ton) of Manufacturers (2021-2026) Table 27. Global Atorvastatin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Atorvastatin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Atorvastatin Manufacturers, Product Type & Application Table 30. Global Atorvastatin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Atorvastatin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Atorvastatin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Atorvastatin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Atorvastatin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Atorvastatin Revenue Market Share by Type (2021-2026) Table 37. Global Atorvastatin Revenue Market Share by Type (2027-2032) Table 38. Global Atorvastatin Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 39. Global Atorvastatin Sales by Type (2021-2026) & (k tons) Table 40. Global Atorvastatin Sales by Type (2027-2032) & (k tons) Table 41. Global Atorvastatin Sales Market Share by Type (2021-2026) Table 42. Global Atorvastatin Sales Market Share by Type (2027-2032) Table 43. Global Atorvastatin Price by Type (2021-2026) & (US$/ton) Table 44. Global Atorvastatin Price by Type (2027-2032) & (US$/ton) Table 45. Global Atorvastatin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Atorvastatin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Atorvastatin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Atorvastatin Revenue Market Share by Application (2021-2026) Table 49. Global Atorvastatin Revenue Market Share by Application (2027-2032) Table 50. Global Atorvastatin Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 51. Global Atorvastatin Sales by Application (2021-2026) & (k tons) Table 52. Global Atorvastatin Sales by Application (2027-2032) & (k tons) Table 53. Global Atorvastatin Sales Market Share by Application (2021-2026) Table 54. Global Atorvastatin Sales Market Share by Application (2027-2032) Table 55. Global Atorvastatin Price by Application (2021-2026) & (US$/ton) Table 56. Global Atorvastatin Price by Application (2027-2032) & (US$/ton) Table 57. Teva Pharmaceutical Industries Company Information Table 58. Teva Pharmaceutical Industries Business Overview Table 59. Teva Pharmaceutical Industries Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical Industries Atorvastatin Product Portfolio Table 61. Teva Pharmaceutical Industries Recent Development Table 62. Sun Pharmaceutical Industries Company Information Table 63. Sun Pharmaceutical Industries Business Overview Table 64. Sun Pharmaceutical Industries Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Sun Pharmaceutical Industries Atorvastatin Product Portfolio Table 66. Sun Pharmaceutical Industries Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Pfizer Atorvastatin Product Portfolio Table 71. Pfizer Recent Development Table 72. Morepen Company Information Table 73. Morepen Business Overview Table 74. Morepen Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Morepen Atorvastatin Product Portfolio Table 76. Morepen Recent Development Table 77. DSM Sinochem Pharmaceuticals Company Information Table 78. DSM Sinochem Pharmaceuticals Business Overview Table 79. DSM Sinochem Pharmaceuticals Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. DSM Sinochem Pharmaceuticals Atorvastatin Product Portfolio Table 81. DSM Sinochem Pharmaceuticals Recent Development Table 82. Combi-Blocks Company Information Table 83. Combi-Blocks Business Overview Table 84. Combi-Blocks Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Combi-Blocks Atorvastatin Product Portfolio Table 86. Combi-Blocks Recent Development Table 87. Cadila Pharmaceuticals Company Information Table 88. Cadila Pharmaceuticals Business Overview Table 89. Cadila Pharmaceuticals Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Cadila Pharmaceuticals Atorvastatin Product Portfolio Table 91. Cadila Pharmaceuticals Recent Development Table 92. Apotex Pharmachem Company Information Table 93. Apotex Pharmachem Business Overview Table 94. Apotex Pharmachem Atorvastatin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Apotex Pharmachem Atorvastatin Product Portfolio Table 96. Apotex Pharmachem Recent Development Table 97. North America Atorvastatin Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Atorvastatin Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Atorvastatin Sales by Type (2021-2026) & (k tons) Table 100. North America Atorvastatin Sales by Type (2027-2032) & (k tons) Table 101. North America Atorvastatin Sales Price by Type (2021-2026) & (US$/ton) Table 102. North America Atorvastatin Sales Price by Type (2027-2032) & (US$/ton) Table 103. North America Atorvastatin Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Atorvastatin Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Atorvastatin Sales by Application (2021-2026) & (k tons) Table 106. North America Atorvastatin Sales by Application (2027-2032) & (k tons) Table 107. North America Atorvastatin Sales Price by Application (2021-2026) & (US$/ton) Table 108. North America Atorvastatin Sales Price by Application (2027-2032) & (US$/ton) Table 109. North America Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Atorvastatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Atorvastatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Atorvastatin Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 113. North America Atorvastatin Sales by Country (2021-2026) & (k tons) Table 114. North America Atorvastatin Sales by Country (2027-2032) & (k tons) Table 115. North America Atorvastatin Sales Price by Country (2021-2026) & (US$/ton) Table 116. North America Atorvastatin Sales Price by Country (2027-2032) & (US$/ton) Table 117. United States Atorvastatin Revenue (2021-2032) & (US$ Million) Table 118. Canada Atorvastatin Revenue (2021-2032) & (US$ Million) Table 119. Mexico Atorvastatin Revenue (2021-2032) & (US$ Million) Table 120. Europe Atorvastatin Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Atorvastatin Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Atorvastatin Sales by Type (2021-2026) & (k tons) Table 123. Europe Atorvastatin Sales by Type (2027-2032) & (k tons) Table 124. Europe Atorvastatin Sales Price by Type (2021-2026) & (US$/ton) Table 125. Europe Atorvastatin Sales Price by Type (2027-2032) & (US$/ton) Table 126. Europe Atorvastatin Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Atorvastatin Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Atorvastatin Sales by Application (2021-2026) & (k tons) Table 129. Europe Atorvastatin Sales by Application (2027-2032) & (k tons) Table 130. Europe Atorvastatin Sales Price by Application (2021-2026) & (US$/ton) Table 131. Europe Atorvastatin Sales Price by Application (2027-2032) & (US$/ton) Table 132. Europe Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Atorvastatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Atorvastatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Atorvastatin Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 136. Europe Atorvastatin Sales by Country (2021-2026) & (k tons) Table 137. Europe Atorvastatin Sales by Country (2027-2032) & (k tons) Table 138. Europe Atorvastatin Sales Price by Country (2021-2026) & (US$/ton) Table 139. Europe Atorvastatin Sales Price by Country (2027-2032) & (US$/ton) Table 140. Germany Atorvastatin Revenue (2021-2032) & (US$ Million) Table 141. France Atorvastatin Revenue (2021-2032) & (US$ Million) Table 142. U.K. Atorvastatin Revenue (2021-2032) & (US$ Million) Table 143. Italy Atorvastatin Revenue (2021-2032) & (US$ Million) Table 144. Russia Atorvastatin Revenue (2021-2032) & (US$ Million) Table 145. Spain Atorvastatin Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Atorvastatin Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Atorvastatin Revenue (2021-2032) & (US$ Million) Table 148. Sweden Atorvastatin Revenue (2021-2032) & (US$ Million) Table 149. Poland Atorvastatin Revenue (2021-2032) & (US$ Million) Table 150. China Atorvastatin Revenue by Type (2021-2026) & (US$ Million) Table 151. China Atorvastatin Revenue by Type (2027-2032) & (US$ Million) Table 152. China Atorvastatin Sales by Type (2021-2026) & (k tons) Table 153. China Atorvastatin Sales by Type (2027-2032) & (k tons) Table 154. China Atorvastatin Sales Price by Type (2021-2026) & (US$/ton) Table 155. China Atorvastatin Sales Price by Type (2027-2032) & (US$/ton) Table 156. China Atorvastatin Revenue by Application (2021-2026) & (US$ Million) Table 157. China Atorvastatin Revenue by Application (2027-2032) & (US$ Million) Table 158. China Atorvastatin Sales by Application (2021-2026) & (k tons) Table 159. China Atorvastatin Sales by Application (2027-2032) & (k tons) Table 160. China Atorvastatin Sales Price by Application (2021-2026) & (US$/ton) Table 161. China Atorvastatin Sales Price by Application (2027-2032) & (US$/ton) Table 162. Asia Atorvastatin Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Atorvastatin Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Atorvastatin Sales by Type (2021-2026) & (k tons) Table 165. Asia Atorvastatin Sales by Type (2027-2032) & (k tons) Table 166. Asia Atorvastatin Sales Price by Type (2021-2026) & (US$/ton) Table 167. Asia Atorvastatin Sales Price by Type (2027-2032) & (US$/ton) Table 168. Asia Atorvastatin Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Atorvastatin Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Atorvastatin Sales by Application (2021-2026) & (k tons) Table 171. Asia Atorvastatin Sales by Application (2027-2032) & (k tons) Table 172. Asia Atorvastatin Sales Price by Application (2021-2026) & (US$/ton) Table 173. Asia Atorvastatin Sales Price by Application (2027-2032) & (US$/ton) Table 174. Asia Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Atorvastatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Atorvastatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Atorvastatin Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 178. Asia Atorvastatin Sales by Country (2021-2026) & (k tons) Table 179. Asia Atorvastatin Sales by Country (2027-2032) & (k tons) Table 180. Asia Atorvastatin Sales Price by Country (2021-2026) & (US$/ton) Table 181. Asia Atorvastatin Sales Price by Country (2027-2032) & (US$/ton) Table 182. Japan Atorvastatin Revenue (2021-2032) & (US$ Million) Table 183. South Korea Atorvastatin Revenue (2021-2032) & (US$ Million) Table 184. India Atorvastatin Revenue (2021-2032) & (US$ Million) Table 185. Australia Atorvastatin Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Atorvastatin Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Atorvastatin Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Atorvastatin Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Atorvastatin Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Atorvastatin Sales by Type (2021-2026) & (k tons) Table 191. SAMEA Atorvastatin Sales by Type (2027-2032) & (k tons) Table 192. SAMEA Atorvastatin Sales Price by Type (2021-2026) & (US$/ton) Table 193. SAMEA Atorvastatin Sales Price by Type (2027-2032) & (US$/ton) Table 194. SAMEA Atorvastatin Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Atorvastatin Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Atorvastatin Sales by Application (2021-2026) & (k tons) Table 197. SAMEA Atorvastatin Sales by Application (2027-2032) & (k tons) Table 198. SAMEA Atorvastatin Sales Price by Application (2021-2026) & (US$/ton) Table 199. SAMEA Atorvastatin Sales Price by Application (2027-2032) & (US$/ton) Table 200. SAMEA Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Atorvastatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Atorvastatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Atorvastatin Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 204. SAMEA Atorvastatin Sales by Country (2021-2026) & (k tons) Table 205. SAMEA Atorvastatin Sales by Country (2027-2032) & (k tons) Table 206. SAMEA Atorvastatin Sales Price by Country (2021-2026) & (US$/ton) Table 207. SAMEA Atorvastatin Sales Price by Country (2027-2032) & (US$/ton) Table 208. Brazil Atorvastatin Revenue (2021-2032) & (US$ Million) Table 209. Argentina Atorvastatin Revenue (2021-2032) & (US$ Million) Table 210. Chile Atorvastatin Revenue (2021-2032) & (US$ Million) Table 211. Colombia Atorvastatin Revenue (2021-2032) & (US$ Million) Table 212. Peru Atorvastatin Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Atorvastatin Revenue (2021-2032) & (US$ Million) Table 214. Israel Atorvastatin Revenue (2021-2032) & (US$ Million) Table 215. UAE Atorvastatin Revenue (2021-2032) & (US$ Million) Table 216. Turkey Atorvastatin Revenue (2021-2032) & (US$ Million) Table 217. Iran Atorvastatin Revenue (2021-2032) & (US$ Million) Table 218. Egypt Atorvastatin Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Atorvastatin Distributors List Table 222. Atorvastatin Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Atorvastatin Image Figure 2. Global Atorvastatin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atorvastatin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chemical Synthesis Image Figure 5. Biocatalysis Image Figure 6. Global Atorvastatin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Atorvastatin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Global Atorvastatin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Atorvastatin Revenue (2021-2032) & (US$ Million) Figure 13. Global Atorvastatin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Atorvastatin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Atorvastatin Revenue Market Share by Region (2021-2032) Figure 16. Global Atorvastatin Sales (2021-2032) & (k tons) Figure 17. Global Atorvastatin Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 18. Global Atorvastatin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Atorvastatin Sales YoY (2021-2032) & (k tons) Figure 20. Europe Atorvastatin Sales YoY (2021-2032) & (k tons) Figure 21. China Atorvastatin Sales YoY (2021-2032) & (k tons) Figure 22. Asia (Excluding China) Atorvastatin Sales YoY (2021-2032) & (k tons) Figure 23. South America, Middle East and Africa Atorvastatin Sales YoY (2021-2032) & (k tons) Figure 24. Global Atorvastatin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Atorvastatin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Atorvastatin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Atorvastatin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Atorvastatin Revenue Market Share by Type (2021-2032) Figure 30. Global Atorvastatin Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 31. Global Atorvastatin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Atorvastatin Sales Market Share by Type (2021-2032) Figure 33. Global Atorvastatin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Atorvastatin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Atorvastatin Revenue Market Share by Application (2021-2032) Figure 36. Global Atorvastatin Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 37. Global Atorvastatin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Atorvastatin Sales Market Share by Application (2021-2032) Figure 39. North America Atorvastatin Revenue Share by Type (2021-2032) Figure 40. North America Atorvastatin Sales Share by Type (2021-2032) Figure 41. North America Atorvastatin Revenue Share by Application (2021-2032) Figure 42. North America Atorvastatin Sales Share by Application (2021-2032) Figure 43. North America Atorvastatin Revenue Share by Country (2021-2032) Figure 44. North America Atorvastatin Sales Share by Country (2021-2032) Figure 45. Europe Atorvastatin Revenue Share by Type (2021-2032) Figure 46. Europe Atorvastatin Sales Share by Type (2021-2032) Figure 47. Europe Atorvastatin Revenue Share by Application (2021-2032) Figure 48. Europe Atorvastatin Sales Share by Application (2021-2032) Figure 49. Europe Atorvastatin Revenue Share by Country (2021-2032) Figure 50. Europe Atorvastatin Sales Share by Country (2021-2032) Figure 51. China Atorvastatin Revenue Share by Type (2021-2032) Figure 52. China Atorvastatin Sales Share by Type (2021-2032) Figure 53. China Atorvastatin Revenue Share by Application (2021-2032) Figure 54. China Atorvastatin Sales Share by Application (2021-2032) Figure 55. Asia Atorvastatin Revenue Share by Type (2021-2032) Figure 56. Asia Atorvastatin Sales Share by Type (2021-2032) Figure 57. Asia Atorvastatin Revenue Share by Application (2021-2032) Figure 58. Asia Atorvastatin Sales Share by Application (2021-2032) Figure 59. Asia Atorvastatin Revenue Share by Country (2021-2032) Figure 60. Asia Atorvastatin Sales Share by Country (2021-2032) Figure 61. SAMEA Atorvastatin Revenue Share by Type (2021-2032) Figure 62. SAMEA Atorvastatin Sales Share by Type (2021-2032) Figure 63. SAMEA Atorvastatin Revenue Share by Application (2021-2032) Figure 64. SAMEA Atorvastatin Sales Share by Application (2021-2032) Figure 65. SAMEA Atorvastatin Revenue Share by Country (2021-2032) Figure 66. SAMEA Atorvastatin Sales Share by Country (2021-2032) Figure 67. Atorvastatin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Atorvastatin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Synthesis
  • Biocatalysis
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Pfizer
  • Morepen
  • DSM Sinochem Pharmaceuticals
  • Combi-Blocks
  • Cadila Pharmaceuticals
  • Apotex Pharmachem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atorvastatin Market by Type
  3. 1.2.1 Global Atorvastatin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chemical Synthesis
  5. 1.2.3 Biocatalysis
  6. 1.3 Atorvastatin Market by Application
  7. 1.3.1 Global Atorvastatin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Retail Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Atorvastatin Market Dynamics
  1. 2.1 Atorvastatin Industry Trends
  2. 2.2 Atorvastatin Industry Drivers
  3. 2.3 Atorvastatin Industry Opportunities and Challenges
  4. 2.4 Atorvastatin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atorvastatin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atorvastatin Revenue by Region
  3. 3.2.1 Global Atorvastatin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atorvastatin Revenue by Region (2021-2026)
  5. 3.2.3 Global Atorvastatin Revenue by Region (2027-2032)
  6. 3.2.4 Global Atorvastatin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atorvastatin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atorvastatin Sales by Region
  9. 3.4.1 Global Atorvastatin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atorvastatin Sales by Region (2021-2026)
  11. 3.4.3 Global Atorvastatin Sales by Region (2027-2032)
  12. 3.4.4 Global Atorvastatin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atorvastatin Revenue by Manufacturers
  2. 4.1.1 Global Atorvastatin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atorvastatin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atorvastatin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atorvastatin Sales by Manufacturers
  6. 4.2.1 Global Atorvastatin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atorvastatin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atorvastatin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atorvastatin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atorvastatin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atorvastatin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atorvastatin Manufacturers, Product Type & Application
  13. 4.7 Global Atorvastatin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atorvastatin Market CR5 and HHI
  16. 4.8.2 2025 Atorvastatin Tier 1, Tier 2, and Tier 3
5 Atorvastatin Market by Type
  1. 5.1 Global Atorvastatin Revenue by Type
  2. 5.1.1 Global Atorvastatin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atorvastatin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atorvastatin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atorvastatin Sales by Type
  6. 5.2.1 Global Atorvastatin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atorvastatin Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Atorvastatin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atorvastatin Price by Type
6 Atorvastatin Market by Application
  1. 6.1 Global Atorvastatin Revenue by Application
  2. 6.1.1 Global Atorvastatin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atorvastatin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atorvastatin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atorvastatin Sales by Application
  6. 6.2.1 Global Atorvastatin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atorvastatin Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Atorvastatin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atorvastatin Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries
  2. 7.1.1 Teva Pharmaceutical Industries Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Atorvastatin Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 7.2 Sun Pharmaceutical Industries
  8. 7.2.1 Sun Pharmaceutical Industries Company Information
  9. 7.2.2 Sun Pharmaceutical Industries Business Overview
  10. 7.2.3 Sun Pharmaceutical Industries Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Industries Atorvastatin Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Atorvastatin Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Morepen
  20. 7.4.1 Morepen Company Information
  21. 7.4.2 Morepen Business Overview
  22. 7.4.3 Morepen Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Morepen Atorvastatin Product Portfolio
  24. 7.4.5 Morepen Recent Developments
  25. 7.5 DSM Sinochem Pharmaceuticals
  26. 7.5.1 DSM Sinochem Pharmaceuticals Company Information
  27. 7.5.2 DSM Sinochem Pharmaceuticals Business Overview
  28. 7.5.3 DSM Sinochem Pharmaceuticals Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 DSM Sinochem Pharmaceuticals Atorvastatin Product Portfolio
  30. 7.5.5 DSM Sinochem Pharmaceuticals Recent Developments
  31. 7.6 Combi-Blocks
  32. 7.6.1 Combi-Blocks Company Information
  33. 7.6.2 Combi-Blocks Business Overview
  34. 7.6.3 Combi-Blocks Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Combi-Blocks Atorvastatin Product Portfolio
  36. 7.6.5 Combi-Blocks Recent Developments
  37. 7.7 Cadila Pharmaceuticals
  38. 7.7.1 Cadila Pharmaceuticals Company Information
  39. 7.7.2 Cadila Pharmaceuticals Business Overview
  40. 7.7.3 Cadila Pharmaceuticals Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cadila Pharmaceuticals Atorvastatin Product Portfolio
  42. 7.7.5 Cadila Pharmaceuticals Recent Developments
  43. 7.8 Apotex Pharmachem
  44. 7.8.1 Apotex Pharmachem Company Information
  45. 7.8.2 Apotex Pharmachem Business Overview
  46. 7.8.3 Apotex Pharmachem Atorvastatin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Apotex Pharmachem Atorvastatin Product Portfolio
  48. 7.8.5 Apotex Pharmachem Recent Developments
8 North America
  1. 8.1 North America Atorvastatin Market Size by Type
  2. 8.1.1 North America Atorvastatin Revenue by Type (2021-2032)
  3. 8.1.2 North America Atorvastatin Sales by Type (2021-2032)
  4. 8.1.3 North America Atorvastatin Price by Type (2021-2032)
  5. 8.2 North America Atorvastatin Market Size by Application
  6. 8.2.1 North America Atorvastatin Revenue by Application (2021-2032)
  7. 8.2.2 North America Atorvastatin Sales by Application (2021-2032)
  8. 8.2.3 North America Atorvastatin Price by Application (2021-2032)
  9. 8.3 North America Atorvastatin Market Size by Country
  10. 8.3.1 North America Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atorvastatin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atorvastatin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Atorvastatin Market Size by Type
  2. 9.1.1 Europe Atorvastatin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atorvastatin Sales by Type (2021-2032)
  4. 9.1.3 Europe Atorvastatin Price by Type (2021-2032)
  5. 9.2 Europe Atorvastatin Market Size by Application
  6. 9.2.1 Europe Atorvastatin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atorvastatin Sales by Application (2021-2032)
  8. 9.2.3 Europe Atorvastatin Price by Application (2021-2032)
  9. 9.3 Europe Atorvastatin Market Size by Country
  10. 9.3.1 Europe Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atorvastatin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atorvastatin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Atorvastatin Market Size by Type
  2. 10.1.1 China Atorvastatin Revenue by Type (2021-2032)
  3. 10.1.2 China Atorvastatin Sales by Type (2021-2032)
  4. 10.1.3 China Atorvastatin Price by Type (2021-2032)
  5. 10.2 China Atorvastatin Market Size by Application
  6. 10.2.1 China Atorvastatin Revenue by Application (2021-2032)
  7. 10.2.2 China Atorvastatin Sales by Application (2021-2032)
  8. 10.2.3 China Atorvastatin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atorvastatin Market Size by Type
  2. 11.1.1 Asia Atorvastatin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atorvastatin Sales by Type (2021-2032)
  4. 11.1.3 Asia Atorvastatin Price by Type (2021-2032)
  5. 11.2 Asia Atorvastatin Market Size by Application
  6. 11.2.1 Asia Atorvastatin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atorvastatin Sales by Application (2021-2032)
  8. 11.2.3 Asia Atorvastatin Price by Application (2021-2032)
  9. 11.3 Asia Atorvastatin Market Size by Country
  10. 11.3.1 Asia Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atorvastatin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atorvastatin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atorvastatin Market Size by Type
  2. 12.1.1 SAMEA Atorvastatin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atorvastatin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atorvastatin Price by Type (2021-2032)
  5. 12.2 SAMEA Atorvastatin Market Size by Application
  6. 12.2.1 SAMEA Atorvastatin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atorvastatin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atorvastatin Price by Application (2021-2032)
  9. 12.3 SAMEA Atorvastatin Market Size by Country
  10. 12.3.1 SAMEA Atorvastatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atorvastatin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atorvastatin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atorvastatin Value Chain Analysis
  2. 13.1.1 Atorvastatin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atorvastatin Production Mode & Process
  6. 13.2 Atorvastatin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atorvastatin Distributors
  9. 13.2.3 Atorvastatin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst